Abstract
Only 15% of human kinases carry a bulky residue at the DFG-1 position, providing an opportunity for the design of selective ATP-site inhibitors without the typical hinge-binding interactions. The low sequence homology among unrelated kinases with bulky DFG-1 residues provides a new paradigm for selective kinase inhibitor development.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 10221-10223 |
| Number of pages | 3 |
| Journal | Journal of medicinal chemistry |
| Volume | 63 |
| Issue number | 18 |
| DOIs | |
| State | Published - Sep 24 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
PubMed: MeSH publication types
- Journal Article
- Comment
Fingerprint
Dive into the research topics of 'DFG-1 Binding: A New Residue for Developing Selective Kinase Inhibitors'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS